NCT01923506View on ClinicalTrials.gov

Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer After Undergoing Surgery

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

November 25, 2013

Primary Completion Date

August 27, 2025

Study Completion Date

August 27, 2025

Conditions
Recurrent Prostate CancerStage I Prostate CancerStage IIA Prostate CancerStage IIB Prostate CancerStage III Prostate Cancer
Interventions
RADIATION

stereotactic body radiation therapy

Undergo SBRT

PROCEDURE

quality-of-life assessment

Ancillary studies

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

91010

City of Hope Medical Center, Duarte

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER

NCT01923506 - Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer After Undergoing Surgery | Biotech Hunter | Biotech Hunter